Juan Carlos Montero González

16PUBLICATIONS
26CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 15, 2026
EIF3E::RSPO2 Fusion in Metastatic Pancreatic Ductal Adenocarcinoma: A Clinical Case Report Suggesting a Putative KRAS-Independent Molecular Profile.

|Jun 25, 2026
Potent anti-tumor activity of CD98hc-targeted antibody-drug conjugates in ovarian cancer.

|Mar 28, 2026
A Complete Response to Immunotherapy in a Patient with Locally Advanced Squamous Cell Lung Cancer Harboring a Novel TMEM178B::BRAF Fusion: A Case Report.

Juan Carlos Redondo-González, Iñigo San Miguel, Marta Rodríguez-González

|May 14, 2025
High-Quality Samples for Next-Generation Sequencing and PD-L1 Assessment in Non-Small Cell Lung Cancer: The Role of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration.

Marta Rodríguez González, Juan Carlos Montero, José María Sayagués

|Dec 17, 2024
Identification and Characterization of a Novel CCDC6::CASP7 Gene Rearrangement in an Advanced Colorectal Cancer Patient: A Case Report.

Juan Carlos Montero, Raquel Tur, Andrea Jiménez-Perez

|Sep 05, 2024
PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2- breast cancer.

Eduardo Terán, Rebeca Lozano, César A Rodríguez

Pageof 3

Frequent Collaborators

8 joint publications

José María Sayagués Manzano

6 joint publications

Marta Rodríguez-González

2 joint publications

Atanasio Pandiella

2 joint publications

Alejandro Olivares-Hernández